Trilogy Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $589K | Buy |
6,745
+35
| +0.5% | +$3.06K | 0.03% | 217 |
|
|
2025
Q1 | $458K | Hold |
6,710
| – | – | 0.02% | 228 |
|
|
2024
Q4 | $522K | Sell |
6,710
-157
| -2% | -$12.2K | 0.03% | 223 |
|
|
2024
Q3 | $460K | Sell |
6,867
-9,420
| -58% | -$632K | 0.02% | 230 |
|
|
2024
Q2 | $1.85M | Buy |
16,287
+12,895
| +380% | +$1.46M | 0.1% | 134 |
|
|
2024
Q1 | $470K | Buy |
+3,392
| New | +$470K | 0.03% | 204 |
|
|
2018
Q4 | – | Sell |
-160
| Closed | -$6K | – | 251 |
|
|
2018
Q3 | $6K | Buy |
+160
| New | +$6K | ﹤0.01% | 372 |
|
|
2018
Q2 | – | Sell |
-140
| Closed | -$3K | – | 586 |
|
|
2018
Q1 | $3K | Buy |
+140
| New | +$3K | ﹤0.01% | 346 |
|